OneSource optimistic on weight-loss drug prospects, raises FY28 revenue guidance to over $500 mn

Read post on livemint.com

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong demand in its drug-device and biologics sectors.